News-Good Doctor

Blog

——

2026.06.18

Reprinted: 2026 Expert Consensus on the Clinical Diagnosis and Treatment of Malignant Peritoneal Mesothelioma (English Version)

Expert consensus on the diagnosis and treatment ofmalignant peritoneal mesothelioma

2026.06.18

Reprinted: 2026 Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Malignant Pleural Effusion Associated with Ovarian Cancer (2026 Edition)

Malignant pleural effusion (MPE) refers to pleural fluid accumulation resulting from primary malignant tumors of the pleura or from metastases of malignancies originating elsewhere that have spread to the pleura.

2026.06.05

Good Doctor · Hyperthermic Perfusion | Exploring the Microscopic World of “Hyperthermic Perfusion”

Good Doctor·Thermal Perfusion, deeply focused on clinical details, scientifically selects the perfusion solution to ensure the efficacy of perfusion therapy.

2026.05.27

Reposted: [Commentary] International Cutting-Edge Advances and Clinical Practice in the Diagnosis and Treatment of Pseudomyxoma Peritonei

The academic study of peritoneal pseudomyxoma (PMP) has been long and tortuous; only over the past four decades has a conceptual framework aligned with the core principles of oncology gradually taken shape.

2026.05.27

Good Doctor·Hyperthermic Perfusion | Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Pseudomyxoma Peritonei (PMP)

PMP is a rare clinical syndrome primarily caused by the dissemination and implantation of mucinous tumor cells within the peritoneal cavity, leading to the accumulation of mucinous ascites.

2026.05.20

Reprinted: [Article] A Multicenter Real-World Study of 940 Cases of Peritoneal Pseudomyxoma Treated with Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy

Objective: Based on multicenter data, to evaluate the long-term survival, perioperative severe adverse events, and prognostic risk factors in patients with peritoneal pseudomyxoma (PMP) treated with cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC).

2026.05.14

Good Doctor・Hyperthermic Intraperitoneal Chemotherapy (GDHIPEC) | Versatile Clinical Applications to Meet Diverse Diagnostic and Therapeutic Needs

The multi‑scenario adaptability of the intracavitary hyperthermic perfusion therapy machine is a crucial support for standardized, comprehensive cancer care. As one of the cutting‑edge devices in clinical oncology, the Xi’an Good Doctor Intracavitary Hyperthermic Perfusion Therapy Machine (GDHIPEC) is compatible with preoperative, intraoperative, and postoperative adjuvant therapies, and can be applied across multiple departments for palliative treatment. It covers various body cavities, including the abdominal and thoracic cavities, and is suitable for treating cancers of the gastrointestinal, gynecological, hepatobiliary, urological, and thoracic systems. Moreover, it enables dual‑mode hyperthermic perfusion—both with and without fluid—for tumors involving the pleura and peritoneum, truly achieving full coverage across departments and disease stages with a single device. This helps hospitals establish a standardized system for the prevention and treatment of intracavitary tumors, balancing clinical efficacy, patient benefits, and the practical value of the equipment.

2026.05.06

Good Doctor·Hyperthermic Perfusion | Bringing the “Effective Treatment Temperature” Truly into Hyperthermia Clinical Practice

< 1...3 4 5...11 > proceed page

· GDHIPEC from China ,

· Caring for Patients Worldwide ·

Tel.: +86 29 82681864

Sales service hotline: +86 15002902555

E-mail: gd029@126.com

Address: Floor 1-2, Left Building No. 1, Huoju Road, East zone of Xi’an High- tech Development District, Xi’an, China

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Internet Drug Information Service Qualification Certificate (Shaanxi)-Non-Operating -2023-0143

Blog

COOKIES

COOKIES

Sorry，The current column has no content!